Loop Diuretics in Chronic Kidney Disease
NCT00478543 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2009-02-04
Summary
The purpose of this study is to verify the efficacy of diuretic therapy on blood pressure control and left ventricular mass in patients affected by chronic kidney disease
Conditions
Interventions
- DRUG
-
Furosemide
Sponsors & Collaborators
-
University of Campania Luigi Vanvitelli
lead OTHER
Principal Investigators
-
Giuseppe Conte, Professor · University of Campania Luigi Vanvitelli
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2008-05-31
- Completion
- 2008-07-31
Countries
- Italy
Study Locations
More Related Trials
-
Effect of Low Versus Standard Dialysate Sodium on 48h Ambulatory BP in Patients With Intradialytic Hypertension
NCT05430438 ·Status: COMPLETED ·Phase: NA
-
Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
NCT06203236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients
NCT02068937 ·Status: COMPLETED ·Phase: NA
-
Intra-Renal Therapy of Diuretic Unresponsive Acute Kidney Injury
NCT01073189 ·Status: WITHDRAWN ·Phase: PHASE4
-
Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload
NCT06166654 ·Status: RECRUITING ·Phase: PHASE4
-
Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
NCT05411991 ·Status: COMPLETED ·Phase: PHASE4
-
Loop Diuretics Administration and Acute Heart Failure
NCT01441245 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Ultra High Dose Diuretics to Treat Heart Failure
NCT06036914 ·Status: COMPLETED ·Phase: PHASE2
-
Sequential Nephron Blockade in Acute Heart Failure
NCT04163588 ·Status: UNKNOWN ·Phase: PHASE3
-
Chlorthalidone in Chronic Kidney Disease
NCT02841280 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Diuretics in Kidney Disease
NCT04542304 ·Status: TERMINATED ·Phase: PHASE2
-
Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF)
NCT02643147 ·Status: COMPLETED ·Phase: PHASE4
-
Mineralocorticoid Receptor Antagonists in End Stage Renal Disease
NCT01691053 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure
NCT00924014 ·Status: UNKNOWN ·Phase: NA
-
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
NCT05498181 ·Status: RECRUITING ·Phase: PHASE2
-
Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy
NCT00335413 ·Status: COMPLETED ·Phase: PHASE4
-
Diuretic/Cool Dialysate Trial
NCT02593526 ·Status: TERMINATED ·Phase: NA
-
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
NCT06209359 ·Status: RECRUITING ·Phase: PHASE1
-
Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure
NCT01973335 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
NCT02606253 ·Status: COMPLETED ·Phase: PHASE4
-
Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study
NCT04465123 ·Status: UNKNOWN ·Phase: PHASE3
-
Diuretics and Volume Overload in Early CKD
NCT05171686 ·Status: COMPLETED ·Phase: PHASE4
-
Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis
NCT00985322 ·Status: COMPLETED ·Phase: PHASE3
-
Increased Activity of ENaC in Proteinuric Kidney Transplant Recipients
NCT03036748 ·Status: COMPLETED ·Phase: NA
-
Comparison of Single and Combination Diuretics in Low-Renin Hypertension
NCT02351973 ·Status: UNKNOWN ·Phase: PHASE4